Clinical Trials Logo

Clinical Trial Summary

To demonstrate the safety and effectiveness of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) compared to the Taxus® Liberté® Stent in the treatment of coronary artery lesions.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00967902
Study type Interventional
Source OrbusNeich
Contact
Status Completed
Phase Phase 2
Start date November 2009
Completion date September 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04573660 - Abbott Vascular Medical Device Registry
Active, not recruiting NCT01972022 - TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography Phase 4
Completed NCT03218787 - XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. N/A